Removing one additional source of strain may have a greater impact.
At a major neurology congress in Geneva, researchers examining records from over 250 million patients uncovered something quietly significant: among adults living with both epilepsy and hearing loss, wearing hearing aids was associated with a 23% lower risk of developing dementia. The finding did not hold for the general population with hearing loss, nor for patients with other chronic conditions — only for those whose brains were already navigating the particular cognitive toll of epilepsy. It is a reminder that the same intervention can mean very different things depending on the terrain of the mind it enters.
- Dementia risk in epilepsy patients with hearing loss is compounded by the condition's tendency to deplete the brain's cognitive reserve, leaving little buffer against additional strain.
- A sweeping analysis of 250 million patient records revealed that hearing aids offered no measurable dementia protection in the general population — making the epilepsy-specific finding all the more unexpected.
- The 23% risk reduction translates to one fewer dementia case for every 37 epilepsy patients who use hearing aids over five years — a modest but meaningful number for a vulnerable group.
- Researchers believe temporal lobe epilepsy, accelerated cognitive decline, and hearing-damaging side effects of some anti-seizure medications create a uniquely fragile neurological environment where hearing correction can tip the balance.
- Because epilepsy patients already see neurologists and specialists regularly, integrating routine hearing assessments into existing care protocols could deliver this benefit with minimal new burden on patients or systems.
At the European Academy of Neurology Congress in Geneva, researchers from University Hospital Zurich and the University of Liverpool presented findings drawn from an analysis of electronic health records covering more than 250 million patients. Their question was pointed: do hearing aids actually reduce dementia risk, or is the link between hearing loss and cognitive decline simply too entangled with aging to be interrupted?
Hearing loss is already recognized as the single largest modifiable risk factor for dementia. Yet when the team examined outcomes across patients with stroke, diabetes, kidney disease, heart failure, migraine, and arthritis — alongside a general hearing-loss population — hearing aid use showed no significant protective effect in any of these groups. The exception was striking: adults living with both epilepsy and hearing loss who wore hearing aids had a 23% lower risk of developing dementia, amounting to one fewer case per 37 users over five years.
Lead author Dr. Carolina Ferreira-Atuesta explained the pattern through the concept of cognitive reserve — the brain's capacity to absorb damage and keep functioning. Most people with hearing loss retain enough reserve to compensate for the extra mental effort impaired hearing demands, so correcting it changes little. Epilepsy, however, erodes that reserve directly. When hearing loss adds further strain to an already taxed system, the cumulative damage becomes more consequential — and removing one source of that strain through hearing aids produces a measurable benefit.
The mechanisms are layered: epilepsy accelerates cognitive decline across a lifetime, temporal lobe epilepsy directly disrupts sound-processing brain regions, and certain anti-seizure medications can themselves cause hearing loss. These overlapping vulnerabilities appear to be what makes this population uniquely responsive to hearing correction.
The practical implication is straightforward. Epilepsy patients already maintain regular contact with neurologists and specialists, meaning routine hearing assessments could be folded into existing care without new infrastructure. A relatively simple and inexpensive intervention, the research suggests, could meaningfully reduce dementia risk in a population already carrying a heavy cognitive burden.
At the European Academy of Neurology Congress in Geneva this week, researchers presented findings that could reshape how doctors think about hearing loss in a specific, vulnerable population. Adults living with both epilepsy and hearing loss who wear hearing aids appear to have a 23% lower risk of developing dementia compared to those who do not use them. The discovery emerged from an analysis of electronic health records spanning more than 250 million patients, a dataset large enough to reveal patterns that smaller studies might miss.
The research team, drawn from University Hospital Zurich and the University of Liverpool, set out to test a question that has lingered in neurology: can hearing aids actually reduce dementia risk, or is the connection between hearing loss and cognitive decline simply too deeply wired into aging itself? Hearing loss has long been recognized as the single largest modifiable risk factor for dementia—meaning it's something doctors can theoretically address. Yet whether correcting it through hearing aids makes a measurable difference has remained uncertain. The researchers combed through the TriNetX network, comparing people with hearing loss who used hearing aids against carefully matched individuals who did not, then examined outcomes across multiple patient groups: those with stroke, type 2 diabetes, chronic kidney disease, heart failure, migraine, and osteoarthritis, alongside the epilepsy cohort.
The results were striking in their specificity. Among the general population with hearing loss, hearing aid use showed no significant association with lower dementia risk. The same held true for patients with stroke, migraine, diabetes, kidney disease, heart failure, or arthritis. But in the epilepsy subgroup—adults carrying both diagnoses—the protective effect emerged clearly. The 23% reduction translated to an absolute risk drop of 2.7 percentage points over five years, which in practical terms means one fewer case of dementia for every 37 people using hearing aids.
Dr. Carolina Ferreira-Atuesta, the study's lead author, offered an explanation rooted in how the brain allocates its resources. Most people with hearing loss, she noted, possess sufficient cognitive reserve—the brain's capacity to maintain function despite age-related wear or disease damage—to absorb the extra mental effort that hearing impairment demands. Correcting that impairment may therefore have limited impact on dementia risk. Epilepsy operates differently. The condition itself often depletes cognitive reserve, leaving less buffer. When hearing loss piles another source of cognitive strain onto an already compromised system, the cumulative effect appears more damaging. Remove one of those strains through hearing aids, and the benefit becomes measurable.
The biological mechanisms underlying this pattern are multiple. Epilepsy is associated with accelerated cognitive decline across the lifespan. Temporal lobe epilepsy, a common form, directly affects brain regions involved in processing sound. Some anti-seizure medications carry hearing loss as a side effect, compounding the problem. These overlapping vulnerabilities may explain why hearing correction matters more in this population than in others.
For clinical practice, the implications are immediate. People with epilepsy already maintain regular contact with healthcare providers—neurologists, epilepsy specialists, nurses. Routine hearing assessments could be woven into that existing care structure without requiring new infrastructure or patient burden. The finding suggests a simple intervention, already available and relatively inexpensive, that could reduce dementia risk in a population already facing cognitive challenges. Whether healthcare systems will act on this insight remains to be seen.
Notable Quotes
Most people with hearing loss have enough cognitive reserve to absorb the extra effort caused by hearing impairment, so correcting it may not have a large effect on dementia risk. Epilepsy is different because cognitive reserve is often already reduced.— Dr. Carolina Ferreira-Atuesta, lead researcher
The Hearth Conversation Another angle on the story
Why does epilepsy seem to be the exception here? Hearing loss affects millions of people without epilepsy.
Epilepsy damages cognitive reserve—the brain's ability to compensate for stress. Most people have enough reserve to handle hearing loss. People with epilepsy don't.
So it's not about the hearing loss itself, but about what else is already broken.
Exactly. The hearing loss is the same. But in epilepsy, it's one more thing the brain can't absorb. Removing it matters more.
Does this mean hearing aids could prevent dementia in epilepsy patients, or just slow it down?
The study shows association, not causation. We can't say hearing aids prevent dementia. We can say people who use them have lower risk. The mechanism likely involves reducing cognitive load.
If someone with epilepsy has normal hearing, they don't need hearing aids.
Right. This only applies to the subset with both conditions. But that's still a meaningful population, and they're already seeing neurologists regularly.
So the practical move is simple: check hearing in epilepsy clinics.
Yes. It's already part of good care in theory. This research gives it weight.